Home/Filings/4/0001384101-25-000026
4//SEC Filing

Leite John 4

Accession 0001384101-25-000026

CIK 0001384101other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:30 PM ET

Size

8.4 KB

Accession

0001384101-25-000026

Insider Transaction Report

Form 4
Period: 2025-02-27
Leite John
Chief Commercial Officer-CLIA
Transactions
  • Tax Payment

    Common Stock

    2025-03-02$34.76/sh7,650$265,91471,420 total
  • Award

    Common Stock

    2025-02-27+11,00684,816 total
  • Sale

    Common Stock

    2025-02-27$33.84/sh5,746$194,44579,070 total
Footnotes (3)
  • [F1]Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein.
  • [F2]Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.
  • [F3]The reporting person is reporting the withholding of 816, 501 and 6,333 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,606, 985 and 12,470 Restricted Stock Units, respectively, granted on September 1, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001991536

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:30 PM ET
Size
8.4 KB